By creator to www.prnewswire.com
DENVER, Might 5, 2020 /PRNewswire/ — As a part of its continued efforts to additional rework affected person care, DaVita at this time unveiled DaVita Venture Group (DVG). This group plans to speed up DaVita’s efforts to develop and deploy options which are designed to enhance the well being care and high quality of life for individuals with kidney illness and associated continual situations.
“Innovation ought to by no means cease when there is a chance to enhance affected person care,” mentioned Javier Rodriguez, CEO of DaVita. “We need to rework kidney well being – from continual kidney illness to transplant – and we’re placing monetary and strategic sources into these options. We imagine we might be the accomplice of alternative for entrepreneurs who need to deliver greatest in school expertise and improvements to market.”
For greater than 20 years, DaVita has been a frontrunner in creating progressive, patient-centric care fashions that make the most of the most recent expertise designed to enhance high quality of life. Leveraging its broad experience, DVG identifies firms and merchandise for strategic partnerships, enterprise funding alternatives, and to incubate transformative options. The group’s focus consists of innovation in digital well being, prescribed drugs, medical units, and care supply fashions. DVG contributes scientific and operational information and seeks to collaborate with different entities to develop, check and convey new applied sciences to market.
“DaVita Enterprise Group goals to seek out new options for our sufferers that transcend dialysis,” mentioned Steve Phillips, vp of innovation for DVG. “We’re excited to fund choose enterprise capital investments in early stage firms, which can have the potential to drive innovation over time.”
Bringing patient-centered continual care to scale requires reimagining well being care because it exists at this time. A typical affected person with end-stage kidney illness is high-risk and high-need. They typically have 4 or extra comorbidities and spend roughly 11 days within the hospital every year. With a concentrate on broadening innovation throughout the continuum, DVG goals to develop entry to care and enhance scientific outcomes whereas additionally rising the adoption of value-based care to scale back prices.
“That is an thrilling time in well being care as entrepreneurs, researchers and trade leaders envision options that might change care supply for the higher,” said Mahesh Krishnan, group vp of analysis and improvement for DVG. “We imagine we might help drive that change, and that DaVita Enterprise Group is a good incubator to assist advance these options to market.”
About DaVita Inc.
DaVita (NYSE: DVA) is a well being care supplier targeted on remodeling care supply to enhance high quality of life for sufferers globally. The corporate is among the largest suppliers of kidney care companies within the U.S. and has been a frontrunner in scientific high quality and innovation for greater than 20 years. By means of DaVita Kidney Care, the corporate treats sufferers with continual kidney failure and finish stage kidney illness. DaVita is dedicated to daring, patient-centric care fashions, implementing the most recent applied sciences and shifting towards built-in care choices for all. By means of these efforts, DaVita has additionally develop into the biggest supplier of house dialysis within the nation. As of December 31, 2019, DaVita served 206,900 sufferers at 2,753 outpatient dialysis facilities in the United States. The corporate additionally operated 259 outpatient dialysis facilities in ten nations worldwide. DaVita has diminished hospitalizations, improved mortality, and labored collaboratively to propel the kidney care trade to undertake an equitable and high-quality commonplace of take care of all sufferers, all over the place. To study extra, go to DaVita.com/About.
All statements on this launch, aside from statements of historic truth, are forward-looking statements and as such are supposed to be lined by the protected harbor for “forward-looking statements” offered by the Personal Securities Litigation Reform Act of 1995. These forward-looking statements are based mostly on DaVita’s present expectations and are based mostly solely on data out there as of the date of this launch. DaVita undertakes no obligation to publicly replace or revise any forward-looking statements, whether or not because of modified circumstances, new data, future occasions or in any other case. Precise future occasions and outcomes may differ materially from any forward-looking statements attributable to quite a few components that contain substantial recognized and unknown dangers and uncertainties. These dangers and uncertainties embody, however usually are not restricted to, these described within the threat components set forth in DaVita Inc.’s Annual Report on Kind 10-Ok for the 12 months ended December 31, 2019, and the dangers and uncertainties mentioned in any subsequent stories that DaVita information or furnishes with the Securities and Change Fee every so often.
— to www.prnewswire.com